Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)
http://report.nih.gov/rcdc/categories/
Table Published: February 1, 2010
This table displays the annual support level for various research, condition, and disease categories based on grants, contracts, and other funding mechanisms used across the National Institutes of Health (NIH).
At the request of Congress, the NIH embarked on a process to provide better consistency and transparency in the reporting of its funded research. This new process, implemented in 2008 through the Research, Condition, and Disease Categorization (RCDC) system, uses sophisticated text data mining (categorizing and clustering using words and multiword phrases) in conjunction with NIH-wide definitions used to match projects to categories. The definitions are a list of terms and concepts selected by NIH scientific experts to define a research category. The research category levels represent the NIH’s best estimates based on the category definitions.
The NIH does not expressly budget by category. The annual estimates reflect amounts that change as a result of science, actual research projects funded, and the NIH budget. The research categories are not mutually exclusive. Individual research projects can be included in multiple categories so amounts depicted within each column of this table do not add up to 100 percent of NIH-funded research.
Consistent with the Administration’s emphasis on transparency, a separate column has been added to distinguish FY 2009 actual support funded from American Recovery & Reinvestment Act (ARRA) accounts from projects funded by regular NIH appropriations. FY 2010 estimates for ARRA reflect only follow-on commitments related to grants awarded in FY 2009.
The FY 2006 and FY2007 data were produced from a reporting process historically used by NIH. The technical elements of the previous reporting process did not have the ability to produce uniform results and led to wide variability in the way research categories were coded. This process caused inconsistencies in reporting data. RCDC use of data mining improves the consistency and eliminates the wide variability in defining the research categories reported. The table shows historical data for FY2006 and FY2007 and data produced with the new RCDC methodology for FY2007 through FY2009. The FY 2010-2011 estimates are based on RCDC actual data.
Total Number of Research/Disease Areas: 218
Click here for instructions on how to use the data table below.
Research/Disease Areas
(Dollars in millions and rounded) FY 2006
Actual FY 2007
Actual
NIH Historical Method 12/ FY 2007
Actual
NIH Revised Method 12/ FY 2008
Actual FY 2009
Actual
(Non-ARRA) FY 2009
Actual
(ARRA) 13/ FY 2010
Estimated
(Non-ARRA) FY 2010
Estimated
(ARRA) 14/ FY 2011
Estimated
Acute Respiratory Distress Syndrome $74 $48 $87 $82 $103 $17 $106 $9 $109
Agent Orange & Dioxin $17 $18 $15 $13 $13 $2 $14 - $14
Aging $2,431 $2,462 $1,879 $1,965 $3,015 $554 $3,093 $363 $3,172
Alcoholism $511 $521 $443 $452 $441 $75 $452 $48 $467
Allergic Rhinitis (Hay Fever) $4 $5 $7 $6 $4 $1 $4 $1 $4
ALS $44 $39 $40 $43 $43 $13 $44 $11 $45
Alzheimer's Disease $643 $645 $411 $412 $457 $77 $469 $58 $480
American Indians / Alaska Natives $155 $141 $159 $142 $169 $19 $173 $6 $177
Anorexia $15 $12 $8 $7 $8 $2 $8 $2 $8
Anthrax $150 $105 $160 $134 $102 $13 $105 $10 $108
Antimicrobial Resistance $221 $269 $209 $228 $251 $52 $257 $24 $265
Aphasia $15 $14 $20 $22 $22 $3 $22 $1 $23
Arctic $17 $19 $25 $22 $28 $6 $29 $1 $29
Arthritis $355 $339 $222 $232 $246 $65 $252 $35 $259
Assistive Technology $182 $184 $192 $215 $249 $43 $256 $26 $262
Asthma $283 $294 $252 $246 $284 $51 $292 $27 $300
Ataxia Telangiectasia $9 $11 $14 $13 $13 $2 $13 $1 $13
Atherosclerosis $337 $347 $468 $460 $495 $112 $508 $91 $522
Attention Deficit Disorder (ADD) $116 $107 $61 $60 $71 $13 $73 $10 $75
Autism $108 $127 $93 $118 $132 $64 $136 $52 $143
Autoimmune Disease $598 $587 $759 $762 $879 $138 $899 $83 $923
Basic Behavioral and Social Science $1,062 $1,104 $1,119 $1,149 $1,410 $206 $1,447 $129 $1,490
Batten Disease $8 $8 $5 $5 $5 $2 $5 $1 $6
Behavioral and Social Science $3,001 $3,060 $3,157 $3,215 $3,471 $582 $3,562 $401 $3,668
Biodefense 1/ $1,766 $1,735 $1,735 $1,736 $1,755 $213 $1,794 $96 $1,853
Bioengineering $1,546 $1,469 $2,610 $2,853 $3,155 $569 $3,229 $318 $3,318
Biotechnology $9,974 $9,814 $5,344 $5,179 $5,619 $1,051 $5,750 $580 $5,911
Brain Cancer $178 $193 $204 $194 $234 $42 $240 $22 $248
Brain Disorders $4,732 $4,670 $3,592 $3,729 $3,538 $685 $3,630 $450 $3,733
Breast Cancer $718 $707 $729 $726 $722 $111 $741 $47 $765
Burden of Illness $508 $524 $60 $48 $43 $11 $44 $6 $46
Cancer $5,575 $5,643 $5,549 $5,570 $5,629 $1,120 $5,781 $346 $6,036
Cardiovascular $2,349 $2,370 $1,942 $2,027 $2,008 $396 $2,058 $298 $2,115
Cerebral Palsy $18 $16 $30 $28 $21 $4 $22 $2 $22
Cervical Cancer $97 $96 $67 $69 $84 $15 $86 $8 $89
Charcot-Marie-Tooth Disease $7 $7 $9 $12 $14 $2 $15 $1 $15
Child Abuse and Neglect Research $38 $38 $41 $30 $32 $5 $33 $4 $34
Childhood Leukemia $53 $55 $50 $39 $47 $12 $48 $9 $50
Chronic Fatigue Syndrome $5 $4 $4 $4 $5 $0 $5 - $5
Chronic Liver Disease and Cirrhosis $408 $379 $253 $241 $274 $37 $280 $25 $287
Chronic Obstructive Pulmonary Disease $67 $91 $72 $75 $96 $18 $98 $14 $101
Climate Change $50 $47 $4 $4 $4 $2 $5 $2 $5
Clinical Research $8,785 $9,116 $9,862 $9,629 $10,336 $1,854 $10,617 $921 $10,931
Clinical Trials $2,767 $2,949 $3,422 $3,562 $2,966 $485 $3,041 $190 $3,132
Colo-Rectal Cancer $269 $282 $273 $274 $281 $48 $288 $20 $297
Comparative Effectiveness Research + - ** + $194 $246 $199 $162 $205
Complementary and Alternative Medicine $301 $299 $426 $430 $513 $70 $526 $43 $541
Conditions affecting unborn children $103 $110 $81 $81 $95 $8 $97 $4 $100
Contraception/Reproduction $335 $314 $460 $473 $427 $65 $437 $31 $449
Cooley's Anemia $42 $34 $22 $22 $21 $3 $22 $3 $22
Cost Effectiveness Research $143 $155 $50 $49 $52 $16 $53 $14 $55
Crohn's Disease $64 $69 $47 $51 $55 $14 $56 $9 $58
Cystic Fibrosis $85 $82 $78 $90 $86 $13 $88 $9 $90
Dental/Oral and Craniofacial Disease $413 $417 $484 $463 $490 $75 $503 $56 $515
Depression $335 $345 $398 $402 $402 $48 $413 $20 $426
Diabetes 2/ $1,038 $1,037 $1,069 $1,080 $1,030 $121 $1,052 $63 $1,078
Diagnostic Radiology $712 $694 $1,046 $1,095 $976 $206 $1,000 $134 $1,027
Diethylstilbestrol (DES) $8 $6 $5 $4 $4 $1 $4 - $4
Digestive Diseases $1,252 $1,234 $1,460 $1,426 $1,538 $243 $1,577 $137 $1,623
Digestive Diseases - (Gallbladder) $7 $6 $6 $7 $7 $1 $7 - $7
Digestive Diseases - (Peptic Ulcer) $17 $23 $15 $14 $17 $3 $18 $2 $18
Down Syndrome $14 $16 $16 $17 $18 $4 $19 $3 $19
Drug Abuse (NIDA Only) 3/ $990 $1,001 $1,001 $1,007 $1,040 $135 $1,068 $113 $1,102
Duchenne/ Becker Muscular Dystrophy $18 $23 $23 $22 $27 $6 $28 $4 $29
Dystonia $19 $16 $18 $15 $16 $2 $17 $1 $17
Eating Disorders 4/ + - ** + $26 $5 $27 $3 $27
Emerging Infectious Diseases $1,857 $1,816 $1,733 $2,098 $2,080 $307 $2,129 $143 $2,194
Emphysema $17 $21 $30 $29 $28 $11 $29 $9 $30
Endometriosis $12 $12 $12 $15 $15 $2 $15 $1 $16
Epilepsy $103 $105 $145 $145 $128 $21 $131 $15 $135
Estrogen $153 $164 $283 $245 $235 $34 $241 $17 $248
Eye Disease And Disorders Of Vision $705 $714 $800 $796 $862 $129 $933 $61 $956
Facioscapulohumeral Muscular Dystrophy $2 $4 $3 $3 $3 $2 $4 $1 $4
Fetal Alcohol Syndrome $29 $34 $32 $34 $34 $7 $35 $4 $36
Fibroid Tumors (Uterine) $15 $14 $20 $16 $18 $2 $19 $1 $19
Fibromyalgia $9 $9 $11 $12 $11 $2 $11 - $12
Food Safety $316 $278 $230 $244 $262 $37 $268 $19 $276
Fragile X Syndrome $20 $27 $22 $26 $27 $5 $28 $4 $29
Frontotemporal Dementia (FTD) $33 $31 $17 $17 $22 $2 $22 $1 $23
Gene Therapy $356 $325 $250 $249 $221 $28 $227 $18 $233
Gene Therapy Clinical Trials $32 $31 $12 $16 $11 $0 $11 - $11
Genetic Testing $417 $395 $402 $383 $316 $76 $324 $53 $334
Genetics $4,878 $4,878 $7,000 $6,872 $7,278 $1,676 $7,459 $792 $7,676
Global Warming Climate Change $58 $56 $1 $1 $3 $1 $3 $1 $3
Health Disparities 5/ $2,766 $2,744 $2,744 $2,614 $2,806 $434 $2,887 - $2,970
Health Effects of Climate Change $157 $164 $258 $286 $179 $35 $183 $17 $188
Health Services $929 $1,023 $730 $743 $1,102 $316 $1,131 $190 $1,165
Heart Disease $2,087 $2,126 $1,126 $1,217 $1,202 $227 $1,232 $161 $1,267
Heart Disease - Coronary Heart Disease $398 $382 $379 $367 $426 $98 $437 $70 $450
Hematology $1,114 $1,128 $881 $894 $908 $151 $931 $88 $959
Hepatitis $177 $174 $176 $180 $178 $23 $182 $15 $187
Hepatitis - A $3 $2 $6 $6 $4 $0 $4 - $5
Hepatitis - B $36 $42 $53 $53 $51 $6 $52 $2 $54
Hepatitis - C $122 $108 $100 $93 $97 $12 $100 $9 $102
HIV/AIDS 6/ $2,902 $2,906 $2,906 $2,928 $3,019 $319 $3,086 - $3,184
Hodgkin's Disease $21 $17 $12 $16 $26 $1 $27 $1 $28
Homelessness $21 $18 $14 $13 $16 $3 $16 $3 $17
Homicide and Legal Interventions $11 $8 $1 * $2 $1 $2 - $2
HPV and/or Cervical Cancer Vaccines $14 $20 $16 $19 $25 $2 $26 $2 $27
Human Fetal Tissue 7/ $23 $19 ** $40 $41 $22 $42 $18 $43
Human Genome $1,065 $1,099 $1,246 $1,259 $1,775 $566 $1,820 $356 $1,875
Huntington's Disease $48 $53 $49 $51 $57 $12 $58 $7 $60
Hyperbaric Oxygen $2 $2 $3 $4 $3 $0 $4 - $4
Hypertension $395 $390 $231 $263 $266 $41 $272 $29 $280
Immunization $1,438 $1,342 $1,713 $1,734 $1,773 $191 $1,815 $80 $1,870
Infant Mortality/ (LBW) $478 $464 $227 $246 $246 $32 $257 $18 $265
Infectious Diseases $3,132 $3,059 $3,433 $3,575 $3,627 $526 $3,712 $251 $3,822
Infertility $40 $51 $65 $73 $75 $17 $77 $13 $82
Inflammatory Bowel Disease $72 $80 $74 $81 $91 $22 $92 $12 $95
Influenza $207 $271 $280 $204 $316 $46 $327 $13 $337
Injury - Childhood Injuries $28 $27 $28 $26 $33 $3 $34 $2 $35
Injury - Trauma - (Head and Spine) $233 $219 $164 $150 $161 $33 $165 $19 $170
Injury - Traumatic brain injury $85 $82 $73 $59 $71 $15 $73 $8 $75
Injury - Unintentional Childhood Injury $25 $21 $17 $15 $19 $1 $19 - $20
Injury (total) Accidents/Adverse Effects $355 $403 $299 $299 $340 $58 $348 $30 $358
Interstitial Cystitis $25 $23 $10 $10 $11 $1 $12 - $12
Kidney Disease $434 $450 $531 $523 $570 $85 $585 $39 $601
Lead Poisoning $15 $15 $13 $9 $11 $3 $11 - $11
Liver Cancer $88 $90 $103 $89 $94 $12 $96 $7 $99
Liver Disease $450 $423 $589 $562 $572 $79 $587 $48 $603
Lung $978 $1,013 $1,169 $1,211 $1,265 $234 $1,297 $142 $1,335
Lung Cancer $266 $249 $164 $169 $178 $36 $183 $20 $188
Lupus $97 $84 $113 $126 $115 $19 $118 $11 $121
Lyme Disease $24 $22 $26 $22 $25 $5 $25 $3 $26
Lymphoma $170 $158 $186 $193 $184 $22 $188 $13 $194
Macular Degeneration $60 $70 $135 $135 $85 $8 $87 $3 $89
Malaria $98 $104 $112 $132 $110 $11 $112 $6 $116
Malaria Vaccine $35 $36 $31 $32 $34 $3 $35 $2 $36
Mental Health $1,824 $1,853 $2,061 $2,086 $2,129 $382 $2,185 $250 $2,252
Mental Retardation (Intellectual and Developmental Disabilities (IDD)) $188 $204 $305 $350 $281 $94 $288 $71 $297
Methamphetamine $45 $45 $66 $67 $69 $13 $70 $13 $72
Mind and Body $136 $133 $571 $567 $494 $90 $507 $75 $521
Minority Health 5/ $2,423 $2,407 $2,407 $2,396 $2,592 $378 $2,667 - $2,743
Mucopolysaccharidoses (MPS) $10 $10 $8 $7 $7 $0 $7 - $7
Multiple Sclerosis $110 $98 $149 $169 $137 $25 $140 $13 $144
Muscular Dystrophy $40 $47 $58 $56 $66 $17 $68 $10 $70
Myasthenia Gravis $9 $6 $10 $9 $9 $3 $9 - $9
Myotonic Dystrophy $7 $8 $9 $9 $9 $4 $10 $2 $10
Nanotechnology 8/ $192 $215 $257 $304 $343 $73 $361 $42 $382
Networking and Information Technology R&D 8/ $423 $507 $959 $911 $1,174 $168 $1,201 $77 $1,235
Neurodegenerative $1,217 $1,166 $1,579 $1,621 $1,553 $262 $1,593 $169 $1,633
Neurofibromatosis $16 $13 $12 $14 $17 $2 $17 $1 $18
Neuropathy $54 $59 $118 $121 $119 $13 $123 $9 $126
Neurosciences $4,830 $4,809 $5,102 $5,224 $5,320 $848 $5,456 $513 $5,605
Nutrition $1,039 $1,075 $1,327 $1,391 $1,400 $205 $1,435 $108 $1,475
Obesity $594 $661 $595 $664 $745 $117 $763 $68 $784
Organ Transplantation $363 $358 $187 $175 $139 $32 $142 $10 $146
Orphan Drug $1,255 $1,158 $653 $645 $441 $118 $453 $55 $467
Osteogenesis Imperfecta $5 $5 $8 $5 $5 $1 $6 - $6
Osteoporosis $169 $164 $167 $183 $198 $21 $203 $10 $209
Otitis Media $17 $15 $20 $18 $15 $7 $16 $2 $16
Ovarian Cancer $102 $103 $89 $96 $102 $13 $105 $6 $108
Paget's Disease $6 $4 $1 $1 $1 $1 $1 - $1
Pain Conditions - Chronic $220 $224 $277 $279 $333 $53 $341 $31 $350
Parkinson's Disease $208 $187 $143 $152 $162 $24 $166 $16 $171
Pediatric $3,161 $3,173 $2,622 $2,771 $2,996 $505 $3,073 $308 $3,166
Pediatric AIDS 9/ $276 $262 $262 $241 $227 $20 $233 - $241
Pediatric Research Initiative $141 $171 ** $209 $214 $256 $219 $205 $226
Pelvic Inflammatory Disease $4 $3 $4 $3 $3 $1 $3 $1 $3
Perinatal - Birth - Preterm (LBW) $374 $351 $181 $197 $177 $23 $181 $15 $186
Perinatal - Neonatal Respiratory Distress Syndrome $8 $9 $23 $18 $31 $5 $31 $3 $32
Perinatal Period - Conditions Originating in Perinatal Period $407 $387 $413 $449 $470 $65 $482 $37 $495
Pick's Disease $1 $1 $3 $2 $2 $0 $2 - $2
Pneumonia $145 $132 $105 $93 $108 $15 $110 $8 $114
Pneumonia & Influenza $351 $405 $382 $295 $392 $58 $402 $21 $414
Polycystic Kidney Disease $32 $36 $33 $41 $38 $7 $39 $4 $40
Prevention $6,815 $6,729 $4,596 $4,623 $5,332 $844 $5,465 $475 $5,626
Prostate Cancer $348 $345 $295 $290 $310 $47 $319 $26 $329
Psoriasis $8 $10 $22 $8 $13 $3 $13 $2 $14
Regenerative Medicine $614 $575 $697 $723 $799 $144 $818 $90 $841
Rehabilitation $324 $344 $379 $403 $404 $75 $415 $56 $446
Rett Syndrome $5 $6 $6 $9 $9 $4 $10 $2 $10
Reye's Syndrome $1 $1 $0 $0 $0 $0 - - -
Rural Health $202 $208 $173 $170 $186 $42 $190 $21 $196
Schizophrenia $364 $358 $220 $249 $265 $85 $272 $44 $280
Scleroderma $11 $12 $12 $20 $21 $2 $22 $1 $22
Septicemia $49 $49 $93 $95 $92 $19 $94 $10 $97
Sexually Transmitted Diseases/Herpes $264 $288 $282 $245 $250 $43 $256 $25 $264
Sickle Cell Disease $91 $94 $78 $80 $63 $14 $64 $10 $66
Sleep Research $199 $190 $219 $225 $217 $33 $223 $19 $229
Small Pox $149 $122 $142 $94 $94 $4 $96 $3 $99
Smoking and Health $517 $534 $324 $310 $329 $78 $338 $46 $358
Spina Bifida $11 $9 $14 $15 $14 $3 $14 $2 $14
Spinal Cord Injury $66 $64 $90 $80 $80 $14 $82 $8 $84
Spinal Muscular Atrophy $15 $11 $11 $10 $11 $3 $11 $3 $12
Stem Cell Research $643 $657 $968 $938 $1,044 $187 $1,070 $112 $1,100
Stem Cell Research - Embryonic - Human 10/ $38 $42 $74 $88 $120 $23 $123 $14 $126
Stem Cell Research - Embryonic - Non-Human $110 $106 $120 $150 $148 $29 $151 $10 $155
Stem Cell Research - Nonembryonic - Human $206 $203 $226 $297 $339 $58 $348 $40 $358
Stem Cell Research - Nonembryonic - Non-Human $289 $306 $400 $497 $550 $88 $564 $52 $580
Stem Cell Research - Umbilical Cord Blood/ Placenta $19 $22 $44 $46 $49 $10 $50 $7 $52
Stem Cell Research - Umbilical Cord Blood/ Placenta - Human $16 $19 $38 $38 $42 $9 $43 $7 $45
Stem Cell Research - Umbilical Cord Blood/ Placenta - Non-Human $4 $2 $9 $9 $10 $1 $10 - $11
Stroke $342 $340 $288 $296 $329 $54 $338 $35 $347
Substance Abuse 11/ $1,490 $1,523 $1,636 $1,763 $1,653 $245 $1,697 $180 $1,750
Sudden Infant Death Syndrome $77 $81 $25 $29 $22 $6 $22 $2 $23
Suicide $32 $43 $52 $39 $36 $15 $37 $3 $38
Teenage Pregnancy $21 $16 $24 $21 $23 $5 $23 $3 $24
Temporomandibular Muscle/Joint Disorder (TMJD) $17 $15 $18 $19 $15 $1 $15 $1 $15
Tobacco $515 $536 $325 $311 $331 $78 $340 $46 $360
Topical Microbicides $88 $99 $92 $102 $92 $7 $124 $1 $130
Tourette Syndrome $13 $11 $9 $8 $7 $3 $7 - $7
Transmissible Spongiform Encephalopathy (TSE) $35 $43 $50 $44 $43 $4 $44 $1 $46
Transplantation $551 $534 $544 $519 $571 $94 $585 $48 $601
Tuberculosis $150 $166 $188 $142 $189 $27 $195 $14 $199
Tuberculosis Vaccine $22 $17 $23 $18 $15 $3 $15 $2 $16
Tuberous Sclerosis $9 $12 $20 $20 $20 $3 $20 $2 $21
Urologic Diseases $536 $526 $535 $534 $578 $81 $594 $39 $612
Uterine Cancer $28 $22 $24 $16 $25 $4 $26 $3 $27
Vaccine Related $1,449 $1,358 $1,659 $1,632 $1,593 $185 $1,631 $77 $1,680
Vaccine related (AIDS) 9/ $566 $597 $597 $556 $561 $35 $567 - $603
Vector-Borne Diseases $464 $424 $478 $417 $401 $66 $411 $38 $423
Violence Against Women $20 $24 $49 $45 $39 $2 $40 $2 $41
Violence Research $113 $106 $190 $183 $182 $21 $187 $16 $192
Vulvodynia + - ** + $1 $1 $1 $1 $1
West Nile Virus $85 $69 $81 $39 $59 $7 $61 $4 $63
Women's Health 5/ $3,498 $3,470 $3,470 $3,514 $3,725 $506 $3,822 - $3,930
Youth Violence $67 $60 $123 $115 $111 $12 $114 $9 $118
[*] The minimum reporting threshold for a specific disease/condition is $500,000. Reporting of $0 does not indicate that no research is being conducted.
[**] No methodology was identified for RCDC in 2007; therefore there is no data available under the “FY 2007 Actual” column.
[+] Indicates a new category. Funding support data not available prior to the actual FY 2009 level reported.
1/ Reporting for this category does not follow the standard RCDC process. The total amount reported is consistent with reporting requirements for this category to the U.S. Office of Management & Budget (OMB). The project listing does not include non-project or other support costs associated with the annual total for this category. Additional information on this category is available at
http://www.niaid.nih.gov/topics/biodefenserelated/pages/default.aspx.
2/ Includes research funded from the Type 1 diabetes appropriation of $150,000,000. These are project listings only.
3/ Reporting for this category does not follow the standard RCDC process. Spending is reported consistent with U.S. Office of National Drug Control Policy (ONDCP) requirements (Only NIDA). More information on this area is available at
http://www.drugabuse.gov/drugpages/.
4/ Reported total for this category encompasses research for anorexia, bulimia nervosa, binge eating disorders, and eating disorders not otherwise specified.
5/ Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system.
6/ Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on this area is available at
http://www.oar.nih.gov/.
7/ Reporting for this category does not follow the standard RCDC process. This category uses a non-standard approach involving subject matter expert reviews of manually collected project listings.
8/ The data provided reflects funding amounts reported by the NIH RCDC process for this category. Actual and estimate levels presented on this site supersede FY 2009-2011 amounts detailed in OMB MAX DE application tables that were based on preliminary FY 2009 funding support information.
9/ Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on the budget associated with the category is available at
http://www.oar.nih.gov/. Research reported for this category is also captured under the broader HIV/AIDS category.
10/ Human embryonic stem cell research projects awarded with restrictions may have been included in the FY2009 report.
11/ Reporting for this category does not follow the standard RCDC process. This category includes all spending reported under the Drug Abuse category as well as projects categorized under the broader area of Substance Abuse. These are project listings only. More information on this area is available at
http://www.drugabuse.gov/drugpages/.
12/ To illustrate the effect of the RCDC methodology change, the table shows a side-by-side comparison of FY 2007 levels produced with the prior method (“NIH Historical Method”) compared with levels that would have resulted if the new methodology had been implemented (“NIH Revised Method”). “NIH Historical Method” figures are considered the official “Actual” for FY 2007. The “NIH Revised Method” levels provide for comparability to FY 2008 RCDC actuals.
13/ A separate column added to distinguish FY 2009 actual support funded from American Recovery & Reinvestment Act (ARRA) accounts from projects funded by regular recurring NIH appropriations.
14/ FY 2010 estimates for ARRA reflect only follow-on commitments related to grants awarded in FY 2009. Obligations associated with potential exercise of option years for contracts let in 2009 or new contracts as well as award of new competing grants are not included.